Employees: 793
Size Beijing Konruns Pharmaceutical (603590.SS) is a China Consumer Staples company (Drugstore Chains) with a market value of $558M, the 3427th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥23.39 on 18 Nov 2026.
Performance Over six months the shares fell 33.3%, against -4.5% for the median peer and -20.0% for the China market (cap-weighted) — 3rd lowest of 15 in its peer set.
Growth Revenue fell 0.8% over the last twelve months (peer median +6.5%); the operating margin is 17.0% (peer median 3.8%).
Valuation It trades at 19.0× forward earnings against a peer median of 13.9× (2nd most expensive of 8).
Price implies For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +10 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.2 points below its cost of capital (7.1% WACC).
Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥863M | CN¥909M | CN¥819M | CN¥914M | CN¥860M |
| Revenue growth | — | +11% | -10% | +6% | — |
| Gross profit | CN¥784M | CN¥795M | CN¥712M | CN¥787M | CN¥708M |
| EBITDA | n/a | CN¥216M | CN¥154M | CN¥172M | CN¥158M |
| Net income | CN¥138M | CN¥166M | CN¥42.2M | CN¥150M | CN¥101M |
| Free cash flow | CN¥21.9M | CN¥83.4M | CN¥88.1M | CN¥113M | CN¥31.8M |
| Capital expenditure | CN¥74.1M | CN¥53.4M | CN¥104M | CN¥101M | CN¥96.3M |
| Total debt | CN¥381M | CN¥333M | CN¥246M | CN¥192M | CN¥12.4M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 603590.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -15.4% | -1.0% | 4th lowest of 15 |
| 6-month return | -33.3% | -4.5% | 3rd lowest of 15 |
| Distance from 52-week high | -51.7% | -35.5% | 3rd lowest of 15 |
| Revenue growth (TTM) | -0.8% | +6.5% | 4th lowest of 15 |
| Operating margin | 17.0% | 3.8% | highest of 15 |
| Forward P/E | 19.0× | 13.9× | 2nd most expensive of 8 |
| Growth the price implies (Req g, 7 yrs) | 12.4% | -7.0% | 3rd most demanding of 13 |
| Growth delivered (Del g) | +2.7% | +11.1% | 2nd lowest of 13 |
| Hurdle (Req g minus delivered) | +9.7 pp | -20.0 pp | 2nd most demanding of 13 |
| ROIC minus cost of capital | -3.2 pp | +2.6 pp | 3rd lowest of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Beijing Konruns Pharmaceutical 603590.SS | China | $558M | -33% | -1% | 17% | 19.0× | 12.4% | +2.7% |
| Qol 3034.T | Japan | $561M | +26% | +5% | 6% | 10.5× | -16.6% | +12.4% |
| Cawachi 2664.T | Japan | $562M | +31% | -1% | 2% | n/a | -6.1% | 0.0% |
| Luyan Pharma 002788.SZ | China | $514M | -32% | +3% | 3% | n/a | -0.4% | +6.5% |
| Shu Yu Civilian Pharmacy 301017.SZ | China | $701M | -11% | +9% | 2% | n/a | 1.1% | +17.4% |
| Genky DrugStores 9267.T | Japan | $728M | +3% | +8% | 5% | 13.9× | n/a | n/a |
| Anhui Huaren Health Pharmaceutical 301408.SZ | China | $745M | -32% | +15% | 8% | n/a | -7.5% | +23.3% |
| MedPlus Health Services MEDPLUS.NS | India | $771M | -36% | +21% | 4% | 33.9× | 18.6% | +17.6% |
| Landfar Bio-medicine 000504.SZ | China | $351M | -22% | +497% | -2% | n/a | n/a | n/a |
| Shanghai No. 1 Pharmacy 600833.SS | China | $299M | -22% | +1% | -1% | n/a | 19.5% | +6.1% |
| JZJ Chain Drugstore Corporation 605266.SS | China | $293M | -35% | -5% | 0% | 6.2× | -9.9% | +14.8% |
| Yixintang Pharmaceutical 002727.SZ | China | $1.16B | +4% | -2% | 3% | 16.6× | -16.0% | +6.5% |
| Ain 9627.T | Japan | $1.25B | +2% | +42% | 4% | 13.8× | -6.5% | +16.9% |
| Create SD 3148.T | Japan | $1.32B | +3% | +9% | 5% | n/a | -11.5% | +8.0% |
| LBX Pharmacy Chain Joint Stock 603883.SS | China | $1.71B | +13% | +3% | 5% | 16.1× | -10.7% | +9.7% |